Work

Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors

Year: 2021

Type: review

Source: Cancer Treatment Reviews

DOI: 10.1016/j.ctrv.2021.102298

Authors: M. Bartoletti, L. Musacchio, G. Giannone, V. Tuninetti, A. Bergamini, G. Scambia, D. Lorusso, G. Valabrega, G. Mangili, F. Puglisi, S. Pignata

Institutions: University of Udine, Centro di Riferimento Oncologico, Agostino Gemelli University Polyclinic, Candiolo Cancer Institute, University of Turin, IRCCS Ospedale San Raffaele, IRCCS San Raffaele Roma, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3202580933

FWCI: 0.506

Cites: 72

Cited by: 25

Related to: 10